TREATMENT OF RESTING ZONE CHONDROCYTES WITH 24,25-DIHYDROXYVITAMIN D-3[24,25-(OH)(2)D-3] INDUCES DIFFERENTIATION INTO A 1,25-(OH)(2)D-3-RESPONSIVE PHENOTYPE CHARACTERISTIC OF GROWTH ZONE CHONDROCYTES

被引:46
作者
SCHWARTZ, Z
DEAN, DD
WALTON, JK
BROOKS, BP
BOYAN, BD
机构
[1] UNIV TEXAS, HLTH SCI CTR, DEPT ORTHOPED, SAN ANTONIO, TX 78284 USA
[2] HEBREW UNIV JERUSALEM, HADASSAH FAC DENT MED, DEPT PERIODONT, IL-92010 JERUSALEM, ISRAEL
[3] UNIV TEXAS, HLTH SCI CTR, DEPT PERIODONT, SAN ANTONIO, TX 78284 USA
[4] UNIV TEXAS, HLTH SCI CTR, DEPT BIOCHEM, SAN ANTONIO, TX 78284 USA
关键词
D O I
10.1210/en.136.2.402
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vitamin D-3 metabolites affect the proliferation and differentiation of cartilage cells. Previous reports have shown that rat costochondral cartilage chondrocytes isolated from the growth zone (GC) respond to 1,25-dihydroxyvitamin D-3 [1,25-(OH)(2)D-3], whereas those from the resting zone (RC) respond to 24,25-(OH)(2)D-3. The aim of the present study was to determine whether 24,25-(OH)(2)D-3 induces differentiation of RC cells into a 1,25-(OH)(2)D-3-responsive GC phenotype. To do this, confluent, fourth passage RC chondrocytes were pretreated for 24, 36, 48, 72, and 120 h with 10(-7) M 24,25-(OH)(2)D-3. The medium was then replaced with new medium containing 10(-10) to 10(-8) M 1,25-(OH)(2)D-3, and the cells were incubated for an additional 24 h. At harvest, DNA synthesis was measured as a function of [H-3]thymidine incorporation; cell maturation was assessed by measuring alkaline phosphatase (ALPase) specific activity. Incorporation of [H-3]uridine was used as a general indicator of RNA synthesis. Matrix protein synthesis was assessed by measuring incorporation of [H-3]proline into collagenase-digestible protein (CDP) and collagenase-nondigestible protein (NCP) as well as (SO4)-S-35 incorporation into proteoglycans. When RC cells were pretreated for 24 h with 24,25-(OH)(2)D-3, they responded like RC cells that had received no pretreatment; further treatment of these cells with 1,25-(OH)(2)D-3 had no effect on ALPase, proteoglycan, or NCP production, but CDP production was inhibited. However, when RC cells were pretreated for 36-120 h with 24,25-(OH)(2)D-3, treatment with 1,25-(OH)(2)D-3 caused a dose-dependent increase in ALPase, CDP, and proteoglycan synthesis, with no effect on NCP production. RC cells pretreated with 1,25-(OH)(2)D-3 responded like RC cells that had not received any pretreatment. To determine whether these responses were specific to chondrocytes in the endochondral pathway, cells were isolated from the xiphoid process, a hyaline cartilage. In these cells, 1,25-(OH)(2)D-3 inhibited ALPase, whereas 36 h of pretreatment with 24,25-(OH)(2)D-3 caused these cells to lose their response to 1,25-(OH)(2)D-3. These results indicate that 24,25-(OH)(2)D-3 can directly regulate the differentiation and maturation of RC chondrocytes into GC chondrocytes, as evidenced by increased responsiveness to 1,25-(OH)(2)D-3 24,25-(OH)(2)D-3 also promotes differentiation of cells derived from xiphoid cartilage, resulting in the loss of 1,25-(OH)(2)D-3 responsiveness. These observations support the hypothesis that 24,25-(OH)(2)D-3 plays a significant role in cartilage development.
引用
收藏
页码:402 / 411
页数:10
相关论文
共 52 条
[1]   EFFECTS OF VITAMIN-D METABOLITES ON HEALING OF LOW PHOSPHATE, VITAMIN-D-DEFICIENT INDUCED RICKETS IN RATS [J].
ATKIN, I ;
PITA, JC ;
ORNOY, A ;
AGUNDEZ, A ;
CASTIGLIONE, G ;
HOWELL, DS .
BONE, 1985, 6 (02) :113-123
[2]  
ATKIN I, 1992, J BONE MINER RES, V7, P863
[3]  
BALMAIN N, 1993, CELL MOL BIOL, V39, P339
[4]   1,25-DIHYDROXYVITAMIN-D3 AND HUMAN BONE-DERIVED CELLS-INVITRO - EFFECTS ON ALKALINE-PHOSPHATASE, TYPE-I COLLAGEN AND PROLIFERATION [J].
BERESFORD, JN ;
GALLAGHER, JA ;
RUSSELL, RGG .
ENDOCRINOLOGY, 1986, 119 (04) :1776-1785
[5]  
BOSKEY AL, 1981, CLIN ORTHOP RELAT R, P225
[6]   THE EFFECTS OF VITAMIN-D METABOLITES ON THE PLASMA AND MATRIX VESICLE MEMBRANES OF GROWTH AND RESTING CARTILAGE CELLS-INVITRO [J].
BOYAN, BD ;
SCHWARTZ, Z ;
CARNES, DL ;
RAMIREZ, V .
ENDOCRINOLOGY, 1988, 122 (06) :2851-2860
[7]   DIFFERENTIAL EXPRESSION OF PHENOTYPE BY RESTING ZONE AND GROWTH REGION COSTOCHONDRAL CHONDROCYTES INVITRO [J].
BOYAN, BD ;
SCHWARTZ, Z ;
SWAIN, LD ;
CARNES, DL ;
ZISLIS, T .
BONE, 1988, 9 (03) :185-194
[8]  
BRETAUDIERE JP, 1984, METHOD ENZYMAT AN, V4, P75
[9]   METABOLIC CONSEQUENCES OF ORAL-ADMINISTRATION OF 24,25-DIHYDROXYCHOLECALCIFEROL TO UREMIC DOGS [J].
CANTERBURY, JM ;
GAVELLAS, G ;
BOURGOIGNIE, JJ ;
REISS, E .
JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (03) :571-576
[10]  
CAPLAN AI, 1994, BONE, V8, P1